Author： Rabuş Şule lzzettin Fikret Sancar Mesut Rabuş Murat Kırma Cevat Yakut Cevat
Publisher： Springer Publishing Company
ISSN： 0928-1231
Source： Pharmacy World and Science, Vol.27, Iss.3, 2005-06, pp. : 243-248
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Cost-Effectiveness Model Of Long-Acting Risperidone in Schizophrenia in the US
PharmacoEconomics, Vol. 23, Iss. 3, 2005-01 ,pp. :
Access to resources
Recommend
A Short Term Cost-Effectiveness Model for Oral Antidiabetic Medicines in Europe
PharmacoEconomics, Vol. 14, Iss. 6, 1998-12 ,pp. :
A Short Term Cost-Effectiveness Model For Oral Antidiabetic Medicines in Europe
By Hood S.C.
PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. :
Cost–effectiveness analysis in pharmacogenomics
By Payne Katherine Shabaruddin Fatiha H
Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. :
Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
By O'Hagan A.
PharmacoEconomics, Vol. 17, Iss. 4, 2000-04 ,pp. :